Dr. Merl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Retired
Centerville, OH 45458- Is this information wrong?
Education & Training
- SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1984
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1978 - 1981
- The Warren Alpert Medical School of Brown UniversityClass of 1978
Certifications & Licensure
- OH State Medical License 1987 - 2018
Publications & Presentations
PubMed
- 62 citationsA phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).Wolfram E. Samlowski, James J. Moon, Ralph J. Tuthill, Michael Heinrich, Naomi S. Balzer-Haas, Stuart A. Merl, Ronald C. DeConti, John A. Thompson, Merle Witter, Lawre...> ;American Journal of Clinical Oncology. 2010 Oct 1
- A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group Study (S0331).Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, DeConti RC, Thompson JA, Flaherty LE, Sondak VK> ;J. Clin. Oncol.. 2009-05-20
- 11 citationsHuman T-lymphotropic virus type I-associated benign transient immature T-cell lymphocytosis.Garth D. Ehrlich, Tin Han, Richard Bettigole, Stuart A. Merl, Bruce M. Lehr, Russell H. Tomar, Bernard J. Poiesz> ;American Journal of Hematology. 1988 Jan 1
- Join now to see all
Professional Memberships
- Member
- Member
External Links
- Kettering Sitehttp://www.ketteringcancercare.org/our-physicians/merl.cfm
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: